Genmab A/S Stock

Genmab A/S Interest Expense

The Interest Expense of Genmab A/S (GMAB.CO) as of Aug 7, 2026 is 173.00 M USD. In the previous year, Interest Expense was 356.93 M USD — a change of -51.53% (lower).

Interest Expense

173.00 MUSD

YoY

-51.53%

Last updated:

Interest Expense of Genmab A/S is 2026 173.00 M USD. Interest Expense of Genmab A/S was 2025 356.93 M USD. It decreases by -51.53% lower compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

Genmab A/S Stock analysis

What does Genmab A/S do? Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab A/S stock

Interest Expense of Genmab A/S is 173.00 M USD in 2026.

Interest Expense of Genmab A/S changed from 356.93 M USD to 173.00 M USD, representing a -51.53% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Expense Genmab A/S since 2006 – with annual values, charts, and detailed analysis.

Interest expense represents the cost of borrowing. Higher interest expenses can indicate a highly leveraged company.

Interest Expense's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Interest Expense's Genmab A/S historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Genmab A/S

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Genmab A/S